Schweitzer Biotech Company Ltd

We provides COVID-19 diagnostic kits (i.e. ELISA kits, qPCR kits, cPCR kits), and also automatic nucleic acid extraction and amplification system.

Scientific Formosa Inc

Minitab helps companies and institutions to identify trends, solve problems and discover valuable insights in data by delivering a comprehensive and best-in-class suite of data analysis and process improvement tools. Combined with unparalleled ease of use, Minitab makes it simpler than ever to get deep insights from data. Plus, a team of highly trained data analytic experts and services ensures that users get the most out of their analyses, enabling them to make better, faster, and more accurate decisions.

SCOHIA PHARNA, Inc.

SCOHIA is a carved-out venture from R&D unit in cardiovascular, metabolic and renal disease areas of Takeda pharmaceutical which is No.1 pharmaceutical in Japan.

SOCIUM Inc

SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months. By taking a systems biology approach using our Augmented intelligence and Machine Learning – instead of hypothesizing the mechanism of a disease and focusing on only a few related compounds, we profile the entire disease by analyzing various OMICS data.

SOFIVA GENOMICS CO., LTD.

SOFIVA GENOMICS is the clinical indicators of prenatal diagnosis, genetic testing and genetic counseling in Taiwan. Beginning from the Molecular Genetics Laboratory of Medical Genetics in National Taiwan University Hospital to SOFIVA GENOMICS today, we established our leading position in the maternal-fetal medicine with continuously developing innovative clinical diagnostic techniques.

SYSMEX TAIWAN CO., LTD.

In line with our mission of “shaping the advancement of healthcare,” which is defined in the “Sysmex Way,” the corporate philosophy of the Sysmex Group, Sysmex works to contribute to the development of healthcare and the healthy lives of people.

Since its establishment in 1968, Sysmex has been providing customers around the world with the solutions that enable in vitro testing of blood and urine samples.

In addition to the fields of hematology, immunochemistry and hemostasis, we have expanded our business to include the life science domain. We are now an integrated manufacturer, developing and manufacturing the instruments, reagents and software that are needed for in vitro diagnostics and providing sales and support service, supporting human health in more than 190 countries and regions around the world.

Recent years have seen aging populations and increasingly diverse healthcare needs in advanced countries, and growing populations and rapid progress in healthcare infrastructures in emerging markets. Against this backdrop, testing and diagnostics have increased in importance, owing to their role in disease prevention and healthcare.

Taiwan AI labs

Driven by the motive to create a novel experience that will define the future of AI-assisted medicine, Taiwan AI Labs, a government supported organization, is empowering the healthcare realm with its medical image, genomics information and clinical data analysis solutions.

AI Hospital
✽ AI Clinic：GenDiseak Inherited Disease Diagnosis Assitant System, DeepMets ® AI-assisted Brain Metastasis Detection System
✽ AI Nursing：AI Sepsis Risk Prediction System
✽ AI Health：tw23 PRS-baed Precision Health System


COVID Solutions
✽Chest X-ray Supportive Detection System: The AI system can automatically detect the suspected area of SARS-CoV-2 infection in lung, and actively warn the medical staff about the suspicious cases.
✽ DockCoV2: Drug discovery using computational protein-ligand docking simulations and collection ligand-related publication with NLP technology. (Demo Site: https://covirus.cc/drugs/)
✽ Yating Medical Voice Assistant Documentation: Entering medical records with automatic speech recognition technology(ASR). Our ASR model will be optimization for specific scenario. (Demo Site: https://www.youtube.com/watch?v=zVONKALLz4w&t=5s )

Taiwan Biophotonic Corporation

oCare Pro 100

Taiwan Blood Services Foundation

In 2001, the Executive Yuan approved the National Blood for National Health Policy to promote the use of blood from blood donation and blood preparation by commissioned manufacturers. The goal is to be self-sufficient and provide the nationals with safe blood preparation for medical use in order to ensure the health of the nationals. According to the National Blood for National Health Policy, the “national blood” is defined as the blood from blood donation by the nationals and the blood preparation thereof. To improve safety and quality of blood preparation and ensure its stable supply, the Plasma Derivatives Act was formulated to authorize the central competent authority to develop the Blood Preparation Development Program to promote relevant development measures to ensure stable supply of blood preparation in the country.
To be in line with the national policy, TBSF screened plasma raw materials that were voluntarily donated from eligible nationals. After the raw materials passed virus mark test and highly sensitive nucleic acid amplification testing (NAT), they were entrusted to the Australian-based PIC/S GMP CSL Behring plasma factory, which has been approved by the Food and Drug Administration, Ministry of Health and Welfare for manufacturing four products: ““TBSF” (20%) Human Albumin Solution, “TBSF” Human Immunoglobulin for Intravenous Use, “TBSF” High Purity Factor VIII / Von Willebrand Factor Concentrate, and“TBSF” High Purity Factor IX Concentrate.
From national plasma raw materials to final “TBSF” blood products, the whole process is checked by the Therapeutic Goods Administration (TGA) in Australia and the Food and Drug Administration, Ministry of Health and Welfare (TFDA) to ensure the quality and safety, from plasma raw materials screening to final blood preparation, is in line with international standards so that the rights and interests of domestic patients are ensured.

TAIWAN RESONANT WAVES RESEARCH CORP.

1. product introduction
2. Research project